<code id='158E338BCB'></code><style id='158E338BCB'></style>
    • <acronym id='158E338BCB'></acronym>
      <center id='158E338BCB'><center id='158E338BCB'><tfoot id='158E338BCB'></tfoot></center><abbr id='158E338BCB'><dir id='158E338BCB'><tfoot id='158E338BCB'></tfoot><noframes id='158E338BCB'>

    • <optgroup id='158E338BCB'><strike id='158E338BCB'><sup id='158E338BCB'></sup></strike><code id='158E338BCB'></code></optgroup>
        1. <b id='158E338BCB'><label id='158E338BCB'><select id='158E338BCB'><dt id='158E338BCB'><span id='158E338BCB'></span></dt></select></label></b><u id='158E338BCB'></u>
          <i id='158E338BCB'><strike id='158E338BCB'><tt id='158E338BCB'><pre id='158E338BCB'></pre></tt></strike></i>

          Home / fashion / knowledge

          knowledge


          knowledge

          author:leisure time    Page View:14241
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In